Zentiva

This page shows the latest Zentiva news and features for those working in and with pharma, biotech and healthcare.

Sanofi warns of difficult few months as diabetes sales slump

said that the last few months have included the pipeline-building acquisitions of Bioverativ and Ablynx and the sale of its Zentiva generics business to a private equity group.

Latest news

Sanofi appoints ex-Roche Reed as new R&D head

Brandicourt has also demonstrated his commitment to pursuing the core pharma business at Sanofi by selling off its Zentiva generics business for 1.9bn ($2.4bn).
Sanofi sells European generics to Advent for $2.4bn

Sanofi has been looking to divest the Zentiva generics unit since 2016 as part of restructuring the business under chief executive Olivier Brandicourt, who said: “Transferring this business to Advent is ... Sanofi bought the foundations of its European
Ten new medicines recommended in Europe

Duloxetine Zentiva (duloxetine) - a copycat of Lilly's Cymbalta - for the treatment of major depressive disorder, diabetic peripheral neuropathic pain and generalised anxiety disorder, also saw a nod from the EMA.
Three cancer immunotherapies amongst new CHMP approvals

Finally, two generic medicines gained positive opinions: Bortezomib Accord (bortezomib) for the treatment of multiple myeloma and mantle cell lymphoma and Pregabalin Zentiva (pregabalin) for the treatment of epilepsy and generalised
Orphan drugs in latest CHMP recommendations

Completing the positive opinions were two new informed consent applications: Sevelamer carbonate Zentiva (sevelamer) from Genzyme for the control of hyperphosphataemia in adults receiving haemodialysis or peritoneal dialysis and Rasagiline

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

Karim Husny moves from Omega Pharma to Alliance Pharmaceuticals

He brings experience in over the counter and consumer healthcare having worked at several European pharmaceutical firms, including Laboratoire de la Mer, Pfizer and Sanofi's Zentiva business.
Watson selects global generics management team

Ramneborn has more than 20 years' experience in the pharmaceutical industry and joined Actavis from Zentiva, where he was vice president and a member of the board of directors since 2003.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Manager, MedicalCommunications/ Healthcare PR: benefits

AM – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Senior Medical Writer: Salary TBC

Senior Account Director – Healthcare Advertising – London: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Freelance Senior Account Manager / Account Director - Healthcare...: £350-400 depending on experience

Home-based Medical Writer – Medical Education: Salary TBC

Programme/ Account Director - Healthcare PR - London: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Freelance AM/ AD Healthcare Advertising: £350-400 depending on experience

Health Consultant - Brand Comms: Competitive Salary

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Digital Health Specialist – Global Agency: Salary TBC

Scientific Director – Medical Communications: Salary TBC

Account Director, Medical Education: Salary TBC

Digital Account Director: Salary TBC

Creative/ Medical Writer: Circa £35, 000 With Benefits

Home-based Senior Medical Writer – Med Ed: Salary TBC

EU Head of Business Development and Client Service: Exceptional packge and bonus

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Associate Director – Social Healthcare – London: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Account Manager, Medical Communications, London: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Measures for measures: Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?: How past failures and emerging biology are reshaping drug development...
Brain power: fresh approaches to Alzheimer’s drug discovery: New alliances are learning from past mistakes and breaking down research barriers...